Article Versions Notes

Kumbrink J, Bohlmann L, Mamlouk S, Redmer T, Peilstöcker D, Li P, Lorenzen S, Algül H, Kasper S, Hempel D, et al. Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL. Cancers. 2022; 14(15):3631. https://doi.org/10.3390/cancers14153631

Kumbrink, Jörg, Lisa Bohlmann, Soulafa Mamlouk, Torben Redmer, Daniela Peilstöcker, Pan Li, Sylvie Lorenzen, Hana Algül, Stefan Kasper, Dirk Hempel, and et al. 2022. "Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL" Cancers 14, no. 15: 3631. https://doi.org/10.3390/cancers14153631

Kumbrink, J., Bohlmann, L., Mamlouk, S., Redmer, T., Peilstöcker, D., Li, P., Lorenzen, S., Algül, H., Kasper, S., Hempel, D., Kaiser, F., Michl, M., Bartsch, H., Neumann, J., Klauschen, F., von Bergwelt-Baildon, M., Modest, D. P., Stahler, A., Stintzing, S., ... Holch, J. W. (2022). Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL. Cancers, 14(15), 3631. https://doi.org/10.3390/cancers14153631